1
|
Nandi S, Chandra S, Sikder R, Bhattacharya S, Ahir M, Biswal D, Adhikary A, Pramanik NR, Lai TK, Drew MGB, Acharya K. Correction to "Characterization and Inception of a Triterpenoid Astrakurkurol, as a Cytotoxic Molecule on Human Hepatocellular Carcinoma Cells, Hep3B". J Agric Food Chem 2024; 72:5088. [PMID: 38408321 DOI: 10.1021/acs.jafc.3c09849] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/28/2024]
|
2
|
Bhattacharya S, Sarker S, Das S, Ahir M, Chattopadhyay S, Ghosh S, Adhikary A. microRNA-205 represses breast cancer metastasis by perturbing the rab coupling protein [RCP]-mediated integrin β1 recycling on the membrane. Apoptosis 2024; 29:191-209. [PMID: 37945815 DOI: 10.1007/s10495-023-01912-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/27/2023] [Indexed: 11/12/2023]
Abstract
During cancer cell invasion, integrin undergoes constant endo/exocytic trafficking. It has been found that the recycling ability of integrin β1 through Rab11-controlled long loop pathways is directly associated with cancer invasion. Previous studies showed that gain-of-function mutant p53 regulates the Rab-coupling protein [RCP]-mediated integrin β1 recycling by inactivating tumor suppressor TAp63. So, we were interested to investigate the involvement of miR-205 in this process. In the current study first, we evaluated that the lower expression of miR-205 in MDA-MB-231 cell line is associated with high motility and invasiveness. Further investigation corroborated that miR-205 directly targets RCP resulting in attenuated RCP-mediated integrin β1 recycling. Overexpression of TAp63 validates our in vitro findings. To appraise the anti-metastatic role of miR-205, we developed two in vivo experimental models- xenograft-chick embryo and xenograft-immunosuppressed BALB/c mice. Our in vivo results support the negative effect of miR-205 on metastasis. Therefore, these findings advocate the tumor suppressor activity of miR-205 in breast cancer cells and suggest that in the future development of miR-205-targeting RNAi therapeutics could be a smart alternative approach to prevent the metastatic fate of the disease.
Collapse
Affiliation(s)
- Saurav Bhattacharya
- Centre for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake, Kolkata, 700106, West Bengal, India
- Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA
| | - Sushmita Sarker
- Centre for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake, Kolkata, 700106, West Bengal, India
| | - Shaswati Das
- Centre for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake, Kolkata, 700106, West Bengal, India
| | - Manisha Ahir
- Centre for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake, Kolkata, 700106, West Bengal, India
- Baylor College of Medicine, Houston, TX, USA
| | - Sreya Chattopadhyay
- Department of Physiology, University of Calcutta, 92 Acharya Prafulla Chandra Road, Kolkata, 700009, West Bengal, India
| | - Swatilekha Ghosh
- Amity Institute of Biotechnology, Amity University, Kolkata. Major Arterial Road [South-East], Action Area II, Newtown, Kolkata, 700135, West Bengal, India
| | - Arghya Adhikary
- Department of Life science & Bio-technology, Jadavpur University, Kolkata, West Bengal, India.
| |
Collapse
|
3
|
Attarde A, Riad TS, Zhang Z, Ahir M, Fu Y. Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography. J Vis Exp 2023. [PMID: 37677008 DOI: 10.3791/65682] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/09/2023] Open
Abstract
Age-related macular degeneration (AMD) is a leading cause of blindness among older individuals, and its prevalence is rapidly increasing due to the aging population. Choroidal neovascularization (CNV) or wet AMD, which accounts for 10%-20% of all AMD cases, is responsible for an alarming 80%-90% of AMD-related blindness. Current anti-VEGF therapies show suboptimal responses in approximately 50% of patients. Resistance to anti-VEGF treatment in CNV patients is often associated with arteriolar CNV, while responders tend to have capillary CNV. While fluorescein angiography (FA) is commonly used to assess leakage patterns in wet AMD patients and animal models, it does not provide information about CNV vascular morphology (arteriolar CNV vs. capillary CNV). This protocol introduces the use of indocyanine green angiography (ICGA) to characterize lesion types in laser-induced CNV mouse models. This method is crucial for investigating the mechanisms and treatment strategies for anti-VEGF resistance in wet AMD. It is recommended to incorporate ICGA alongside FA for comprehensive assessment of both leakage and vascular features of CNV in mechanistic and therapeutic studies.
Collapse
Affiliation(s)
| | | | - Zhao Zhang
- Cullen Eye Institute, Baylor College of Medicine
| | - Manisha Ahir
- Cullen Eye Institute, Baylor College of Medicine
| | - Yingbin Fu
- Cullen Eye Institute, Baylor College of Medicine;
| |
Collapse
|
4
|
Mukherjee S, Gupta P, Ghosh S, Choudhury S, Das A, Ahir M, Adhikary A, Chattopadhyay S. Targeted tumor killing by pomegranate polyphenols: Pro-oxidant role of a classical antioxidant. J Nutr Biochem 2023; 115:109283. [PMID: 36791995 DOI: 10.1016/j.jnutbio.2023.109283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2022] [Revised: 01/03/2023] [Accepted: 02/08/2023] [Indexed: 02/16/2023]
Abstract
One of the key biochemical features that distinguish a cancer cell from normal cells is its persistent pro-oxidative state that leads to intrinsic oxidative stress. Malignant cells have evolved sophisticated adaptation systems that involve high dependency on antioxidant functions and upregulation of pro-survival molecules to counteract the deleterious effects of reactive species and to maintain dynamic redox balance. This situation renders them vulnerable to further oxidative challenges by exogenous agents. In the present study, we advocated that pomegranate polyphenols act as pro-oxidants and trigger ROS-mediated apoptosis in cancer cells. With the help of both in vitro and in vivo models, we have established that pomegranate fruit extract (PFE) can cause a significant reduction in tumor proliferation while leaving normal tissues and cells unharmed. Administration of PFE (0.2% v/v) in Erhlich's ascites carcinoma-bearing mice for 3 weeks, inhibited the nuclear factor (erythroid-derived 2)-like 2-antioxidant response element signaling cascade, increased intracellular reactive oxygen species content, altered glutathione cycle thereby activating reactive oxygen species-induced apoptotic pathway in Erhlich's ascites carcinoma cells. Moreover, PFE mitigated epithelial to mesenchymal transition and migration in triple negative breast cancer cells (MDA-MB 231 cells) by down-regulating nuclear factor kappa light-chain-enhancer of activated B cells. Pre-treatment of tumor cells with N-acetyl cysteine protected these cells from undergoing PFE-induced apoptosis while siRNA-mediated silencing of Nuclear factor (erythroid-derived 2)-like 2 and nuclear factor kappa light-chain-enhancer of activated B cells in tumor cells increased the cytotoxic potential and pro-oxidative activity of PFE, indicating a clear role of these transcription factors in orchestrating the anticancer/pro-oxidative properties of PFE. The seminal findings provided may be exploited to develop potential therapeutic targets for selective killing of malignant cells.
Collapse
Affiliation(s)
| | - Payal Gupta
- Department of Physiology, University of Calcutta, Kolkata, India
| | - Sayan Ghosh
- Department of Physiology, University of Calcutta, Kolkata, India
| | | | - Ankur Das
- Department of Physiology, University of Calcutta, Kolkata, India
| | - Manisha Ahir
- Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, Kolkata, India
| | - Arghya Adhikary
- Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, Kolkata, India
| | - Sreya Chattopadhyay
- Department of Physiology, University of Calcutta, Kolkata, India; Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, Kolkata, India.
| |
Collapse
|
5
|
Ebrahimpour A, Ahir M, Wang M, Jegga AG, Bonnen MD, Eissa NT, Montesi SB, Raghu G, Ghebre YT. Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis. Sci Rep 2022; 12:20668. [PMID: 36450789 PMCID: PMC9712660 DOI: 10.1038/s41598-022-24985-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Accepted: 11/23/2022] [Indexed: 12/03/2022] Open
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease of unknown etiology. Currently, pirfenidone and nintedanib are the only FDA-approved drugs for the treatment of IPF and are now the standard of care. This is a significant step in slowing down the progression of the disease. However, the drugs are unable to stop or reverse established fibrosis. Several retrospective clinical studies indicate that proton pump inhibitors (PPIs; FDA-approved to treat gastroesophageal reflux) are associated with favorable outcomes in patients with IPF, and emerging preclinical studies report that PPIs possess antifibrotic activity. In this study, we evaluated the antifibrotic efficacy of the PPI esomeprazole when combined with pirfenidone in vitro and in vivo. In cell culture studies of IPF lung fibroblasts, we assessed the effect of the combination on several fibrosis-related biological processes including TGFβ-induced cell proliferation, cell migration, cell contraction, and collagen production. In an in vivo study, we used mouse model of TGFβ-induced lung fibrosis to evaluate the antifibrotic efficacy of esomeprazole/pirfenidone combination. We also performed computational studies to understand the molecular mechanisms by which esomeprazole and/or pirfenidone regulate lung fibrosis. We found that esomeprazole significantly enhanced the anti-proliferative effect of pirfenidone and favorably modulated TGFβ-induced cell migration and contraction of collagen gels. We also found that the combination significantly suppressed collagen production in response to TGFβ in comparison to pirfenidone monotherapy. In addition, our animal study demonstrated that the combination therapy effectively inhibited the differentiation of lung fibroblasts into alpha smooth muscle actin (αSMA)-expressing myofibroblasts to attenuate the progression of lung fibrosis. Finally, our bioinformatics study of cells treated with esomeprazole or pirfenidone revealed that the drugs target several extracellular matrix (ECM) related pathways with esomeprazole preferentially targeting collagen family members while pirfenidone targets the keratins. In conclusion, our cell biological, computational, and in vivo studies show that the PPI esomeprazole enhances the antifibrotic efficacy of pirfenidone through complementary molecular mechanisms. This data supports the initiation of prospective clinical studies aimed at repurposing PPIs for the treatment of IPF and other fibrotic lung diseases where pirfenidone is prescribed.
Collapse
Affiliation(s)
- Afshin Ebrahimpour
- grid.39382.330000 0001 2160 926XDepartment of Radiation Oncology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030 USA
| | - Manisha Ahir
- grid.39382.330000 0001 2160 926XDepartment of Radiation Oncology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030 USA
| | - Min Wang
- grid.39382.330000 0001 2160 926XDepartment of Radiation Oncology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030 USA
| | - Anil G. Jegga
- grid.24827.3b0000 0001 2179 9593Division of Biomedical Informatics, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH 45229 USA
| | - Mark D. Bonnen
- grid.267309.90000 0001 0629 5880Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 USA
| | - N. Tony Eissa
- grid.266093.80000 0001 0668 7243Department of Medicine, University of California, Irvine School of Medicine, Irvine, CA 92697 USA
| | - Sydney B. Montesi
- grid.32224.350000 0004 0386 9924Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA 02114 USA
| | - Ganesh Raghu
- grid.34477.330000000122986657Division of Pulmonary and Critical Care Medicine, Center for Interstitial Lung Disease, University of Washington, Seattle, WA 98195 USA
| | - Yohannes T. Ghebre
- grid.39382.330000 0001 2160 926XDepartment of Radiation Oncology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030 USA ,grid.267309.90000 0001 0629 5880Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 USA ,grid.39382.330000 0001 2160 926XDepartment of Medicine, Section on Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX 77030 USA ,grid.39382.330000 0001 2160 926XDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030 USA
| |
Collapse
|
6
|
Ghosh A, Upadhyay P, Sarker S, Das S, Bhattacharjee M, Bhattacharya S, Ahir M, Guria S, Gupta P, Chattopadhyay S, Ghosh S, Adhikari S, Adhikary A. Delivery of novel coumarin-dihydropyrimidinone conjugates through mixed polymeric nanoparticles to potentiate therapeutic efficacy against triple-negative breast cancer. Biomater Sci 2021; 9:5665-5690. [PMID: 34259681 DOI: 10.1039/d1bm00424g] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
To date, most of the accessible therapeutic options are virtually non-responsive towards triple-negative breast cancer (TNBC) due to its highly aggressive and metastatic nature. Interestingly, chemotherapy reacts soundly in many TNBC cases compared to other types of breast cancer. However, the side effects of many chemotherapeutic agents are still under cross-examination, and thus prohibit their extensive uses. In this present study, we have developed a series of coumarin-dihydropyrimidinone conjugates (CDHPs) and subsequently their poly(lactic-co-glycolic acid) (PLGA)-PEG4000 mixed copolymer nanoparticles as excellent chemotherapeutic nanomedicine to control TNBC. Among all the synthesized CDHPs, CDHP-4 (prepared by the combination of EDCO with 3,4-difluorobenzaldehyde) showed excellent therapeutic effect on a wide variety of cancer cell lines, including TNBC. Besides, it can control the metastasis and stemness property of TNBC. Furthermore, the nano-encapsulation of CDHP-4 in a mixed polymer nanoparticle system (CDHP-4@PP-NPs) and simultaneous delivery showed much improved therapeutic efficacy at a much lower dose, and almost negligible side effects in normal healthy cells or organs. The effectiveness of the present therapeutic agent was observed both in intravenous and oral mode of administration in in vivo experiments. Moreover, on elucidating the molecular mechanism, we found that CDHP-4@PP-NPs could exhibit apoptotic, anti-migratory, as well as anti-stemness activity against TNBC cell lines through the downregulation of miR-138. We validated our findings in MDA-MB-231 xenograft chick embryos, as well as in 4T1-induced mammary tumor-bearing BALB/c mice models, and studied the bio-distribution of CDHP-4@PP-NPs on the basis of the photoluminescence property of nanoparticles. Our recent study, hence for the first time, unravels the synthesis of CDHP-4@PP-NPs and the molecular mechanism behind the anti-migration, anti-stemness and anti-tumor efficacy of the nanoparticles against the TNBC cells through the miR-138/p65/TUSC2 axis.
Collapse
Affiliation(s)
- Avijit Ghosh
- Center for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake, Kolkata-700106, West Bengal, India.
| | - Priyanka Upadhyay
- Center for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake, Kolkata-700106, West Bengal, India.
| | - Sushmita Sarker
- Center for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake, Kolkata-700106, West Bengal, India.
| | - Shaswati Das
- Center for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake, Kolkata-700106, West Bengal, India.
| | - Mousumi Bhattacharjee
- Center for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake, Kolkata-700106, West Bengal, India.
| | - Saurav Bhattacharya
- Center for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake, Kolkata-700106, West Bengal, India.
| | - Manisha Ahir
- Center for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake, Kolkata-700106, West Bengal, India.
| | - Subhajit Guria
- Department of Chemistry, University of Calcutta, 92 Acharya Prafulla Chandra Road, Kolkata-700009, West Bengal, India
| | - Payal Gupta
- Department of Physiology, University of Calcutta, 92 Acharya Prafulla Chandra Road, Kolkata-700009, West Bengal, India
| | - Sreya Chattopadhyay
- Department of Physiology, University of Calcutta, 92 Acharya Prafulla Chandra Road, Kolkata-700009, West Bengal, India
| | - Swatilekha Ghosh
- Amity Institute of Biotechnology, Amity University, Rajarhat, New Town, Kolkata-700156, West Bengal, India
| | - Susanta Adhikari
- Department of Chemistry, University of Calcutta, 92 Acharya Prafulla Chandra Road, Kolkata-700009, West Bengal, India
| | - Arghya Adhikary
- Center for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake, Kolkata-700106, West Bengal, India.
| |
Collapse
|
7
|
Upadhyay P, Bhattacharjee M, Bhattacharya S, Ahir M, Adhikary A, Patra P. Silymarin-Loaded, Lactobionic Acid-Conjugated Porous PLGA Nanoparticles Induce Apoptosis in Liver Cancer Cells. ACS Appl Bio Mater 2020; 3:7178-7192. [PMID: 35019376 DOI: 10.1021/acsabm.0c00987] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
HepG2 cells (HCC), characterized by epithelial-like morphology, high proliferation rates, and nontumorigenicity, require cost-effective and efficient treatment. Silymarin, a flavonoid extract of Silybum marianum, is effective in the treatment of HCC. Here, we have reported a comparative anticancer study of the well-characterized nanoformulations of lactobionic acid-adorned porous PLGA-encapsulated silymarin (LA-PLGA-Sil) with only porous PLGA-encapsulated silymarin (PLGA-Sil) against HepG2 cells. Treatment of HepG2 cells with LA-PLGA-Sil produced a significant deterioration in cell viability at an essentially low dose as compared with PLGA-Sil, due to the adorned lactobionic acid moiety, which results in better targeting. p53, a tumor suppressor gene, essentially initiates apoptosis in cells procuring wild-type p53 (p53 +/+). In our report, treatment of HepG2 cells (p53 +/+) with LA-PLGA-Sil activated p53, which in turn inhibited the proliferation of cells by instigating cell-cycle arrest and apoptosis in a concentration-dependent manner and simultaneously stabilized the nuclear translocation of NFκB-p65. To explore the effect of LA-PLGA-Sil on the expression of microRNA, we observed that LA-PLGA-Sil markedly upregulated the miR-29b in human HCC cells. Reactivation of the p53 gene by miR-29b targeted Bcl-2 and triggered the sequential activation of mediators such as proapoptotic Bax protein, release of cytochrome c, and the activation of caspase proteins (caspase-3 and caspase-9). Furthermore, the overexpression of NFκB-p65 in HepG2 cells reversed the repression, and this stabilization effect of LA-PLGA-Sil on the nuclear translocation of p65 led to the significant downregulation of miR-29b and successively decreased the p53 expression in LA-PLGA-Sil-treated cells, thereby providing a survival mechanism to HepG2. In entirety, our study demonstrated the extensive potential of LA-PLGA-Sil to instigate the cell death of HepG2 cells via apoptosis by targeting the miR-29b/p53 axis through the stabilization of NFκB. It also impaired the migratory activity of HepG2 cells and thereby furnished a comprehensive way to HCC therapeutic treatment.
Collapse
Affiliation(s)
- Priyanka Upadhyay
- Centre for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD2, Sector III, Salt Lake City, Kolkata 700106, India
| | - Mousumi Bhattacharjee
- Centre for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD2, Sector III, Salt Lake City, Kolkata 700106, India
| | - Saurav Bhattacharya
- Centre for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD2, Sector III, Salt Lake City, Kolkata 700106, India
| | - Manisha Ahir
- Centre for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD2, Sector III, Salt Lake City, Kolkata 700106, India
| | - Arghya Adhikary
- Centre for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD2, Sector III, Salt Lake City, Kolkata 700106, India
| | - Prasun Patra
- Amity Institute of Biotechnology, Amity University, Major Arterial Road (South-East), Action Area II, Newtown, Kolkata, West Bengal 700135, India
| |
Collapse
|
8
|
Bhattacharya S, Ghosh A, Maiti S, Ahir M, Debnath GH, Gupta P, Bhattacharjee M, Ghosh S, Chattopadhyay S, Mukherjee P, Adhikary A. Delivery of thymoquinone through hyaluronic acid-decorated mixed Pluronic® nanoparticles to attenuate angiogenesis and metastasis of triple-negative breast cancer. J Control Release 2020; 322:357-374. [DOI: 10.1016/j.jconrel.2020.03.033] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2019] [Revised: 03/06/2020] [Accepted: 03/23/2020] [Indexed: 02/07/2023]
|
9
|
Ahir M, Upadhyay P, Ghosh A, Sarker S, Bhattacharya S, Gupta P, Ghosh S, Chattopadhyay S, Adhikary A. Delivery of dual miRNA through CD44-targeted mesoporous silica nanoparticles for enhanced and effective triple-negative breast cancer therapy. Biomater Sci 2020; 8:2939-2954. [PMID: 32319481 DOI: 10.1039/d0bm00015a] [Citation(s) in RCA: 53] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
The development of new therapeutic strategies to target triple-negative breast cancer (TNBC) is in much demand to overcome the roadblocks associated with the existing treatment procedures. In this regard, therapies targeting the CD44 receptor have drawn attention for more than a decade. MicroRNAs (miRNAs) modulate post-transcriptional gene regulation and thus, the correction of specific miRNA alterations using miRNA mimics or antagomiRs is an emerging strategy to normalize the genetic regulation in the tumor microenvironment. It has been acknowledged that miR-34a is downregulated and miR-10b is upregulated in TNBC, which promotes tumorigenesis and metastatic dissemination. However, there are a few barriers related to miRNA delivery. Herein, we have introduced tailored mesoporous silica nanoparticles (MSNs) for the co-delivery of miR-34a-mimic and antisense-miR-10b. MSN was functionalized with a cationic basic side chain and then loaded with the dual combination to overexpress miR-34a and downregulate miR-10b simultaneously. Finally, the loaded MSNs were coated with an hyaluronic acid-appended PEG-PLGA polymer for specific targeting. The cellular uptake, release profile, and subsequent effect in TNBC cells were evaluated. In vitro and in vivo studies demonstrated high specificity in TNBC tumor targeting, leading to efficient tumor growth inhibition as well as the retardation of metastasis, which affirmed the clinical application potential of the system.
Collapse
Affiliation(s)
- Manisha Ahir
- Center for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake City, Kolkata 700106, India.
| | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Nandi S, Chandra S, Sikder R, Bhattacharya S, Ahir M, Biswal D, Adhikary A, Pramanik NR, Lai TK, Drew MGB, Acharya K. Characterization and Inception of a Triterpenoid Astrakurkurol, as a Cytotoxic Molecule on Human Hepatocellular Carcinoma Cells, Hep3B. J Agric Food Chem 2019; 67:7660-7673. [PMID: 31250646 DOI: 10.1021/acs.jafc.9b01203] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Mushrooms are customary influential sources of pharmaceutically active metabolites. Usually lanostane-type triterpenoids from mushrooms had prospective for cancer disease treatments. Recently, a triterpenoid, astrakurkurol obtained from the fresh basidiocarps of the edible mushroom Astraeus hygrometricus, drew attention as a new cytotoxic therapeutic. The structural stability of this triterpenoid had been established with the amalgamation of density functional theory (DFT) calculations and study of single-crystal X-ray diffraction. To successfully manifest astrakurkurol as a potent cytotoxic therapeutics, a wide apprehension on the molecular and cellular mechanisms underlying their action is prerequisite. On this account, our study was directed to scrutinize the influence of this triterpenoid on human hepatocellular cancer cell model Hep3B. Encapsulating all experimental facts revealed that astrakurkurol had significantly decreased cell viability in a concentration-dependent manner. This effect was unveiled to be apoptosis, documented by DNA fragmentation, chromatin condensation, nuclear shrinkage, membrane blebing, and imbalance of cell cycle distribution. Astrakurkurol persuaded the expression of death receptor associated proteins (Fas), which triggered caspase-8 activation following tBid cleavage. Moreover, tBid mediated ROS generation, which triggered mitochondrial dysfunction and activated the mitochondrial apoptotic events. Astrakurkurol cytotoxicity was based on caspase-8-mediated intrinsic apoptotic pathway and was associated with inhibition at Akt and NF-κB pathway. Astrakurkurol had also inhibited the migration of Hep3B cells, indicating its antimigratory potential. These findings led us to introduce astrakurkurol as a feasible and natural source for a safer cytotoxic drug against hepatocellular carcinoma.
Collapse
Affiliation(s)
- Sudeshna Nandi
- Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany , University of Calcutta , 35, Ballygunge Circular Road , Kolkata , WB 700019 , India
| | - Swarnendu Chandra
- Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany , University of Calcutta , 35, Ballygunge Circular Road , Kolkata , WB 700019 , India
| | - Rimpa Sikder
- Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany , University of Calcutta , 35, Ballygunge Circular Road , Kolkata , WB 700019 , India
| | - Saurav Bhattacharya
- Centre for Research in Nanoscience and Nanotechnology , University of Calcutta , JD-2, Sector III, Salt Lake , Kolkata , WB 700098 , India
| | - Manisha Ahir
- Centre for Research in Nanoscience and Nanotechnology , University of Calcutta , JD-2, Sector III, Salt Lake , Kolkata , WB 700098 , India
| | - Debanjana Biswal
- Department of Chemistry , University College of Science , 92, Acharya Prafulla Chandra Road , Kolkata , WB 700009 , India
| | - Arghya Adhikary
- Centre for Research in Nanoscience and Nanotechnology , University of Calcutta , JD-2, Sector III, Salt Lake , Kolkata , WB 700098 , India
| | - Nikhil Ranjan Pramanik
- Department of Chemistry , Bidhannagar College , EB-2, Salt lake , Kolkata 700064 , India
| | - Tapan Kumar Lai
- Department of Chemistry , Vidyasagar Evening College , 39, Sankar Ghosh Lane , Kolkata 700006 , India
| | - Michael G B Drew
- Department of Chemistry , University of Reading , Whiteknights, Reading RG6 6AD , United Kingdom
| | - Krishnendu Acharya
- Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany , University of Calcutta , 35, Ballygunge Circular Road , Kolkata , WB 700019 , India
| |
Collapse
|
11
|
Adhikari S, Ta S, Ghosh A, Guria S, Pal A, Ahir M, Adhikary A, Hira SK, Manna PP, Das D. A 1,8 naphthalimide anchor rhodamine B based FRET probe for ratiometric detection of Cr3+ion in living cells. J Photochem Photobiol A Chem 2019. [DOI: 10.1016/j.jphotochem.2018.12.010] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
12
|
Upadhyay P, Sarker S, Ghosh A, Gupta P, Das S, Ahir M, Bhattacharya S, Chattopadhyay S, Ghosh S, Adhikary A. Transferrin-decorated thymoquinone-loaded PEG-PLGA nanoparticles exhibit anticarcinogenic effect in non-small cell lung carcinoma via the modulation of miR-34a and miR-16. Biomater Sci 2019; 7:4325-4344. [DOI: 10.1039/c9bm00912d] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
The detailed molecular mechanism of transferrin-tagged thymoquinone nanoparticle mediated apoptotic induction in non-small cell lung carcinoma showing the involvement of p53 dependent synergistic activation of miR-34a and miR-16 in the pathway.
Collapse
Affiliation(s)
- Priyanka Upadhyay
- Center for Research in Nanoscience and Nanotechnology
- Technology Campus
- University of Calcutta
- Kolkata-700106
- India
| | - Sushmita Sarker
- Center for Research in Nanoscience and Nanotechnology
- Technology Campus
- University of Calcutta
- Kolkata-700106
- India
| | - Avijit Ghosh
- Center for Research in Nanoscience and Nanotechnology
- Technology Campus
- University of Calcutta
- Kolkata-700106
- India
| | - Payal Gupta
- Department of Physiology
- University of Calcutta
- Kolkata
- India
| | - Shaswati Das
- Center for Research in Nanoscience and Nanotechnology
- Technology Campus
- University of Calcutta
- Kolkata-700106
- India
| | - Manisha Ahir
- Center for Research in Nanoscience and Nanotechnology
- Technology Campus
- University of Calcutta
- Kolkata-700106
- India
| | - Saurav Bhattacharya
- Center for Research in Nanoscience and Nanotechnology
- Technology Campus
- University of Calcutta
- Kolkata-700106
- India
| | | | - Swatilekha Ghosh
- Amity School of Biotechnology
- Amity University
- Kolkata
- Kolkata
- India
| | - Arghya Adhikary
- Center for Research in Nanoscience and Nanotechnology
- Technology Campus
- University of Calcutta
- Kolkata-700106
- India
| |
Collapse
|
13
|
Dey C, Ghosh A, Ahir M, Ghosh A, Goswami MM. Cover Feature: Improvement of Anticancer Drug Release by Cobalt Ferrite Magnetic Nanoparticles through Combined pH and Temperature Responsive Technique (ChemPhysChem 21/2018). Chemphyschem 2018. [DOI: 10.1002/cphc.201800911] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Chaitali Dey
- Centre for Research in Nanoscience & Nanotechnology; University of Calcutta, Block-JD-2, Sector-III, Salt Lake; Kolkata- 700106
| | - Arup Ghosh
- Department of Physics; National University of Singapore; 2 Science Drive 3, Blk S12 Singapore 117551
| | - Manisha Ahir
- Centre for Research in Nanoscience & Nanotechnology; University of Calcutta, Block-JD-2, Sector-III, Salt Lake; Kolkata- 700106
| | - Ajay Ghosh
- Department of Applied Optics and Photonics; University of Calcutta, Block-JD-2, Sector-III, Salt Lake; Kolkata- 700106
| | - Madhuri Mandal Goswami
- Centre for Research in Nanoscience & Nanotechnology; University of Calcutta, Block-JD-2, Sector-III, Salt Lake; Kolkata- 700106
- S.N. Bose National Centre for Basic Sciences, Block-JD, Sector-III, Salt Lake; Kolkata- 700106
| |
Collapse
|
14
|
Dey C, Ghosh A, Ahir M, Ghosh A, Goswami MM. Improvement of Anticancer Drug Release by Cobalt Ferrite Magnetic Nanoparticles through Combined pH and Temperature Responsive Technique. Chemphyschem 2018; 19:2872-2878. [PMID: 30133086 DOI: 10.1002/cphc.201800535] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2018] [Indexed: 12/18/2022]
Abstract
This work reports the application possibilities of cobalt ferrite (CoFe2 O4 ) magnetic nanoparticles (CFMNPs) for stimuli responsive drug delivery by magnetic field induced hyperthermia technique. The CFMNPs were characterized by X-ray diffraction (XRD) with Rietveld analysis, field emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM), selected area electron diffraction (SAED), fourier transform infrared spectroscopy (FTIR), thermogravimetry and differential thermal analysis (TG-DTA), vibrating sample magnetometer (VSM) and superconducting quantum interference device (SQUID) magnetometry. Particles were functionalized with folic acid (FA) by EDC-NHS coupling method and loaded with anticancer drug (DOX) by activated folate ions. The drug release was studied as a function of time at two different temperatures (37 and 44 °C) under pH∼5.5 and 7. It was observed that the drug release rate is higher at elevated temperature (44 °C) and acidic pH∼5.5 as compared to our normal body temperature and pH∼7 using the CFMNPs. This way, we have developed a pH and temperature sensitive drug delivery system, which can release the anticancer drug selectively by applying ac magnetic field as under ac field particles are heated up. We have calculated the amount of heat generation by the particles around 1.67 °C per second at ∼600 Hz frequency. By MTT assay on cancer cell and normal cell, it was confirmed that CFMNPs are nontoxic and biocompatible in nature, which assures that our synthesized particles can be successfully used in localized cancer treatment by stimuli responsive drug delivery technique.
Collapse
Affiliation(s)
- Chaitali Dey
- Centre for Research in Nanoscience & Nanotechnology, University of Calcutta, Block-JD-2, Sector-III, Salt Lake, Kolkata-, 700106
| | - Arup Ghosh
- Department of Physics, National University of Singapore, 2 Science Drive 3, Blk S12, Singapore, 117551
| | - Manisha Ahir
- Centre for Research in Nanoscience & Nanotechnology, University of Calcutta, Block-JD-2, Sector-III, Salt Lake, Kolkata-, 700106
| | - Ajay Ghosh
- Department of Applied Optics and Photonics, University of Calcutta, Block-JD-2, Sector-III, Salt Lake, Kolkata-, 700106
| | - Madhuri Mandal Goswami
- Centre for Research in Nanoscience & Nanotechnology, University of Calcutta, Block-JD-2, Sector-III, Salt Lake, Kolkata-, 700106.,S.N. Bose National Centre for Basic Sciences, Block-JD, Sector-III, Salt Lake, Kolkata-, 700106
| |
Collapse
|
15
|
Sinha A, Banerjee K, Banerjee A, Sarkar A, Ahir M, Adhikary A, Chatterjee M, Choudhuri SK. Induction of apoptosis in human colorectal cancer cell line, HCT-116 by a vanadium- Schiff base complex. Biomed Pharmacother 2017; 92:509-518. [PMID: 28575808 DOI: 10.1016/j.biopha.2017.05.108] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2017] [Revised: 05/20/2017] [Accepted: 05/22/2017] [Indexed: 01/17/2023] Open
Abstract
Vanadium compounds are well known for their therapeutic interventions against several diseases. Various biochemical attributes of vanadium complexes inspired us to evaluate the cancer cell killing efficacy of the vanadium complex, viz., vanadyl N-(2-hydroxyacetophenone) glycinate [VO(NG)2]. Previously we showed that VO(NG)2 is an effective anticancer agent in in vitro and in vivo cancer models and imposed miniscule side effects. Herein we report that VO(NG)2 is significantly cytotoxic to various cancer cell lines. Furthermore, this redox active vanadyl complex altered the redox homeostatsis of many human cancer cell lines significantly. VO(NG)2 actuates programmed cell death in human colorectal carcinoma cells(HCT-116) through mitochondrial outer membrane permeabilization but in caspase independent manner, possibly by altering cellular redox status and by inflicting DNA damage. Thus, the present work is an attempt to provide many evidences regarding the potent and selective chemotherapeutic efficacy of the novel VO(NG)2.
Collapse
Affiliation(s)
- Abhinaba Sinha
- Department of In Vitro Carcinogenesis and Cellular Chemotherapy, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700 026, India
| | - Kaushik Banerjee
- Department of In Vitro Carcinogenesis and Cellular Chemotherapy, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700 026, India
| | - Arpita Banerjee
- Department of In Vitro Carcinogenesis and Cellular Chemotherapy, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700 026, India
| | - Avijit Sarkar
- Department of Pharmacology, Institute of Post Graduate Medical Education and Research, 244, A.J.C. Bose Road, Kolkata 700020, India
| | - Manisha Ahir
- Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, India
| | - Arghya Adhikary
- Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, India
| | - Mitali Chatterjee
- Department of Pharmacology, Institute of Post Graduate Medical Education and Research, 244, A.J.C. Bose Road, Kolkata 700020, India
| | - Soumitra Kumar Choudhuri
- Department of In Vitro Carcinogenesis and Cellular Chemotherapy, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700 026, India.
| |
Collapse
|
16
|
Roy A, Ahir M, Bhattacharya S, Parida PK, Adhikary A, Jana K, Ray M. Induction of mitochondrial apoptotic pathway in triple negative breast carcinoma cells by methylglyoxal via generation of reactive oxygen species. Mol Carcinog 2017; 56:2086-2103. [PMID: 28418078 DOI: 10.1002/mc.22665] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2016] [Revised: 03/14/2017] [Accepted: 04/13/2017] [Indexed: 12/21/2022]
Abstract
Triple negative breast cancer (TNBC) tends to form aggressive tumors associated with high mortality and morbidity which urge the need for development of new therapeutic strategies. Recently, the normal metabolite Methylglyoxal (MG) has been documented for its anti-proliferative activity against human breast cancer. However, the mode of action of MG against TNBC remains open to question. In our study, we investigated the anticancer activity of MG in MDA MB 231 and 4T1 TNBC cell lines and elucidated the underlying mechanisms. MG dose-dependently caused cell death, induced apoptosis, and generated ROS in both the TNBC cell lines. Furthermore, such effects were attenuated in presence of ROS scavenger N-Acetyl cysteine. MG triggered mitochondrial cytochrome c release in the cytosol and up-regulated Bax while down-regulated anti-apoptotic protein Bcl-2. Additionally, MG treatment down-regulated phospho-akt and inhibited the nuclear translocation of the p65 subunit of NF-κB. MG exhibited a tumor suppressive effect in BALB/c mouse 4T1 breast tumor model as well. The cytotoxic effect was studied using MTT assay. Apoptosis, ROS generation, and mitochondrial dysfunction was evaluated by flow cytometry as well as fluorescence microscopy. Western blot assay was performed to analyze proteins responsible for apoptosis. This study demonstrated MG as a potent anticancer agent against TNBC both in vitro and in vivo. The findings will furnish fresh insights into the treatment of this subgroup of breast cancer.
Collapse
Affiliation(s)
- Anirban Roy
- Department of Biophysics, Bose Institute, Kolkata, West Bengal, India
| | - Manisha Ahir
- Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, Kolkata, West Bengal, India
| | - Saurav Bhattacharya
- Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, Kolkata, West Bengal, India
| | | | - Arghya Adhikary
- Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, Kolkata, West Bengal, India
| | - Kuladip Jana
- Division of Molecular Medicine, Bose Institute, Kolkata, West Bengal, India
| | - Manju Ray
- Department of Biophysics, Bose Institute, Kolkata, West Bengal, India
| |
Collapse
|
17
|
Chakraborty A, Debnath GH, Ahir M, Bhattacharya S, Upadhyay P, Adhikary A, Mukherjee P. Towards the realization of luminescence from visible emitting trivalent lanthanides (Sm, Eu, Tb, Dy) in polar zinc sulfide nanoparticles: evaluation of in vitro cytotoxicity. RSC Adv 2016. [DOI: 10.1039/c6ra03401b] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
This study develops water dispersible trivalent terbium cation incorporated zinc sulfide nanoparticles for potential anti-cancer therapy and cellular imaging.
Collapse
Affiliation(s)
- Arijita Chakraborty
- Centre for Research in Nanoscience and Nanotechnology
- University of Calcutta
- Kolkata-700106
- India
| | - Gouranga H. Debnath
- Centre for Research in Nanoscience and Nanotechnology
- University of Calcutta
- Kolkata-700106
- India
| | - Manisha Ahir
- Centre for Research in Nanoscience and Nanotechnology
- University of Calcutta
- Kolkata-700106
- India
| | - Saurav Bhattacharya
- Centre for Research in Nanoscience and Nanotechnology
- University of Calcutta
- Kolkata-700106
- India
| | - Priyanka Upadhyay
- Centre for Research in Nanoscience and Nanotechnology
- University of Calcutta
- Kolkata-700106
- India
| | - Arghya Adhikary
- Centre for Research in Nanoscience and Nanotechnology
- University of Calcutta
- Kolkata-700106
- India
| | - Prasun Mukherjee
- Centre for Research in Nanoscience and Nanotechnology
- University of Calcutta
- Kolkata-700106
- India
| |
Collapse
|
18
|
Patra P, Mitra S, Das Gupta A, Pradhan S, Bhattacharya S, Ahir M, Mukherjee S, Sarkar S, Roy S, Chattopadhyay S, Adhikary A, Goswami A, Chattopadhyay D. Simple synthesis of biocompatible biotinylated porous hexagonal ZnO nanodisc for targeted doxorubicin delivery against breast cancer cell: In vitro and in vivo cytotoxic potential. Colloids Surf B Biointerfaces 2015; 133:88-98. [PMID: 26093304 DOI: 10.1016/j.colsurfb.2015.05.052] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2014] [Revised: 05/26/2015] [Accepted: 05/31/2015] [Indexed: 01/15/2023]
Abstract
Targeted drug delivery with porous materials features great promise as improved therapeutic potential for treatment of various diseases. In the present study we have attempted a microwave synthesis of porous hexagonal nanodisc of zinc oxide (PZHD) for the first time and its subsequent targeted delivery to breast cancer cells, MCF7. PZHD has been fabricated suitably with 3-aminopropyltriethoxysilane to impart additional stability and surface amines to anchor site directing ligand NHS-biotin. Biotinylated scaffold showed targeted delivery of anticancer drug doxorubicin and pH triggered release to MCF 7 cells with preferential distribution on specified domain. A detailed in vitro cytotoxicity study was associated with it to evaluate the mode of action of Dox loaded PZHD on MCF-7 cells by means of cell cycle analysis, apoptosis assays, Western blot and immuno-fluorescence image analysis. The efficacy of the Dox loaded PZHD was further validated from our in vivo tumor regression studies. Finally, the whole study has been supported by in vitro and in vivo bio-safety studies which also signified its biocompatibility with real time applications. To the best of our knowledge this is the first effort to use biotinylated PZHD for targeted delivery of doxorubicin within MCF 7 cells with a detailed study of its mechanistic application. This study might thus hold future prospects for therapeutic intervention for treatment of cancer.
Collapse
Affiliation(s)
- Prasun Patra
- Centre for Research in NanoScience and NanoTechnology, Technology Campus, University of Calcutta, JD 2, Sec III, Salt lake, Kolkata 700098, India.
| | - Shouvik Mitra
- Biological Sciences Division, Indian Statistical Institute, 203 B.T. Road, Kolkata 700108, India
| | - Amarto Das Gupta
- Department of Biotechnology, Birla Institute of Technology and Science, Vidya Vihar, Pilani, Rajasthan 333031, India
| | - Saheli Pradhan
- Biological Sciences Division, Indian Statistical Institute, 203 B.T. Road, Kolkata 700108, India
| | - Saurav Bhattacharya
- Centre for Research in NanoScience and NanoTechnology, Technology Campus, University of Calcutta, JD 2, Sec III, Salt lake, Kolkata 700098, India
| | - Manisha Ahir
- Centre for Research in NanoScience and NanoTechnology, Technology Campus, University of Calcutta, JD 2, Sec III, Salt lake, Kolkata 700098, India
| | - Sudeshna Mukherjee
- Department of Physiology, University College of Science and Technology, University of Calcutta, 92 A.P.C. Road, Kolkata 700009, India
| | - Sampad Sarkar
- Biological Sciences Division, Indian Statistical Institute, 203 B.T. Road, Kolkata 700108, India
| | - Subhrodeb Roy
- Biological Sciences Division, Indian Statistical Institute, 203 B.T. Road, Kolkata 700108, India
| | - Sreya Chattopadhyay
- Department of Physiology, University College of Science and Technology, University of Calcutta, 92 A.P.C. Road, Kolkata 700009, India
| | - Arghya Adhikary
- Centre for Research in NanoScience and NanoTechnology, Technology Campus, University of Calcutta, JD 2, Sec III, Salt lake, Kolkata 700098, India
| | - Arunava Goswami
- Biological Sciences Division, Indian Statistical Institute, 203 B.T. Road, Kolkata 700108, India
| | - Dhrubajyoti Chattopadhyay
- Centre for Research in NanoScience and NanoTechnology, Technology Campus, University of Calcutta, JD 2, Sec III, Salt lake, Kolkata 700098, India
| |
Collapse
|
19
|
Bhattacharya S, Ahir M, Patra P, Mukherjee S, Ghosh S, Mazumdar M, Chattopadhyay S, Das T, Chattopadhyay D, Adhikary A. PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a. Biomaterials 2015; 51:91-107. [PMID: 25771001 DOI: 10.1016/j.biomaterials.2015.01.007] [Citation(s) in RCA: 70] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2014] [Revised: 12/23/2014] [Accepted: 01/20/2015] [Indexed: 01/09/2023]
Abstract
Thymoquinone (TQ), a major active constituent of black seeds of Nigella sativa, has potential medical applications including spectrum of therapeutic properties against different cancers. However, little is known about their effect on breast cancer cell migration, which is the cause of over 90% of deaths worldwide. Herein, we have synthesized TQ-encapsulated nanoparticles using biodegradable, hydrophilic polymers like polyvinylpyrrolidone (PVP) and polyethyleneglycol (PEG) to overcome TQ's poor aqueous solubility, thermal and light sensitivity as well as consequently, minimal systemic bioavailability which can greatly improve the cancer treatment efficiency. Sizes of synthesized TQ-Nps were found to be below 50 nm and they were mostly spherical in shape with smooth surface texture. Estimation of the zeta potential also revealed that all the three TQ-Nps were negatively charged which also facilitated their cellular uptake. In the present investigation, we provide direct evidence that TQ-Nps showed more efficiency in killing cancer cells as well as proved to be less toxic to normal cells at a significantly lower dose than TQ. Interestingly, evaluation of the anti-migratory effect of the TQ-Nps, revealed that PEG4000-TQ-Nps showed much potent anti-migratory properties than the other types. Further studies indicated that PEG4000-TQ-Nps could significantly increase the expression of miR-34a through p53. Moreover, NPs mediated miR-34a up-regulation directly down-regulated Rac1 expression followed by actin depolymerisation thereby disrupting the actin cytoskeleton which leads to significant reduction in the lamellipodia and filopodia formation on cell surfaces thus retarding cell migration. Considering the biodegradability, non-toxicity and effectivity of PEG4000-TQ-Nps against cancer cell migration, TQ-Nps may provide new insights into specific therapeutic approach for cancer treatment.
Collapse
Affiliation(s)
- Saurav Bhattacharya
- Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, JD-2, Sector III, Salt Lake, Kolkata 700098, West Bengal, India
| | - Manisha Ahir
- Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, JD-2, Sector III, Salt Lake, Kolkata 700098, West Bengal, India
| | - Prasun Patra
- Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, JD-2, Sector III, Salt Lake, Kolkata 700098, West Bengal, India
| | - Sudeshna Mukherjee
- Department of Physiology, University of Calcutta, 92 Acharya Prafulla Chandra Road, Kolkata 700009, West Bengal, India
| | - Swatilekha Ghosh
- Division of Molecular Medicine, Bose Institute, P-1/12, Calcutta Improvement Trust Scheme VII M, Kolkata 700054, West Bengal, India
| | - Minakshi Mazumdar
- Division of Molecular Medicine, Bose Institute, P-1/12, Calcutta Improvement Trust Scheme VII M, Kolkata 700054, West Bengal, India
| | - Sreya Chattopadhyay
- Department of Physiology, University of Calcutta, 92 Acharya Prafulla Chandra Road, Kolkata 700009, West Bengal, India
| | - Tanya Das
- Division of Molecular Medicine, Bose Institute, P-1/12, Calcutta Improvement Trust Scheme VII M, Kolkata 700054, West Bengal, India
| | - Dhrubajyoti Chattopadhyay
- Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, JD-2, Sector III, Salt Lake, Kolkata 700098, West Bengal, India
| | - Arghya Adhikary
- Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, JD-2, Sector III, Salt Lake, Kolkata 700098, West Bengal, India.
| |
Collapse
|
20
|
Sardar D, Neogi SK, Bandyopadhyay S, Satpati B, Ahir M, Adhikary A, Jain R, Gopinath CS, Bala T. Multifaceted core–shell nanoparticles: superparamagnetism and biocompatibility. NEW J CHEM 2015. [DOI: 10.1039/c5nj01481f] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
A facile method for the synthesis of NicoreAgshell and NicoreAushell nanoparticles with suitable surface modification for the latter has been demonstrated with potential applications.
Collapse
Affiliation(s)
| | - S. K. Neogi
- CRNN
- University of Calcutta
- Salt Lake
- India
- Department of Physics
| | | | - Biswarup Satpati
- Surface Physics and Material Science Division
- Saha Institute of Nuclear Physics
- Kolkata-64
- India
| | | | | | - Ruchi Jain
- Catalysis Division and Center of Excellence on Surface Science
- CSIR – National Chemical Laboratory
- Pune-411 008
- India
| | - Chinnakonda S. Gopinath
- Catalysis Division and Center of Excellence on Surface Science
- CSIR – National Chemical Laboratory
- Pune-411 008
- India
| | - Tanushree Bala
- Department of Chemistry
- University of Calcutta
- Kolkata
- India
- CRNN
| |
Collapse
|
21
|
Pal S, Ahir M, Sil PC. Doxorubicin-induced neurotoxicity is attenuated by a 43-kD protein from the leaves ofCajanus indicusL. via NF-κB and mitochondria dependent pathways. Free Radic Res 2012; 46:785-98. [PMID: 22448708 DOI: 10.3109/10715762.2012.678841] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
|
22
|
Sood R, Kathuria S, Ahmad H, Ahir M. UP.34: A Comparative Head-On Efficacy Study of 3 Monthly Goserelin 10.8 Mg, 3 Monthly Leuprolide 11.25 Mg and 3 Monthly Leuprolide 22.5 Mg with 6 Monthly Leuprolide 45mg Preparations for Treatment in Patients with Prostate Cancer. Urology 2008. [DOI: 10.1016/j.urology.2008.08.357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|